NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/13/2026 11:28
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.93 mln
Float10.85 mln
Earnings Date09/09/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-5.35
Highly reliable
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
4.01
Highly leveraged
ROE
-531
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Mainz Biomed is a German medical company founded in 2008 that creates and sells stool-based tests designed to detect cancers early, including colorectal and pancreatic cancer. The company serves customers across the United States and Europe, running its own diagnostic laboratory while also supplying testing kits to independent labs. It works alongside Thermo Fisher Scientific to bring its colorectal cancer screening products to a wider market.
